Alerts will be sent to your verified email
Verify EmailSAKAR
|
Sakar Healthcare
|
Gufic Biosciences
|
Caplin Point Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.14 % | 16.89 % | 19.84 % |
|
5yr average Equity Multiplier
|
1.76 | 2.16 | 1.15 |
|
5yr Average Asset Turnover Ratio
|
0.45 | 0.75 | 0.68 |
|
5yr Avg Net Profit Margin
|
10.03 % | 10.24 % | 25.35 % |
|
Price to Book
|
2.91 | 5.32 | 4.69 |
|
P/E
|
45.15 | 51.65 | 25.16 |
|
5yr Avg Cash Conversion Cycle
|
18.72 Days | -15.25 Days | 70.68 Days |
|
Inventory Days
|
51.79 Days | 71.73 Days | 66.07 Days |
|
Days Receivable
|
53.06 Days | 106.89 Days | 110.7 Days |
|
Days Payable
|
115.64 Days | 179.29 Days | 85.23 Days |
|
5yr Average Interest Coverage Ratio
|
4.85 | 8.9 | 633.04 |
|
5yr Avg ROCE
|
8.92 % | 17.89 % | 24.45 % |
|
5yr Avg Operating Profit Margin
|
24.94 % | 18.12 % | 31.52 % |
|
5 yr average Debt to Equity
|
0.49 | 0.67 | 0.0 |
|
5yr CAGR Net Profit
|
10.38 % | -2.66 % | 17.23 % |
|
5yr Average Return on Assets
|
4.54 % | 7.7 % | 17.23 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.86 % | 72.5 % | 70.57 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-9.24 % | -2.5 % | 1.69 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 2.45 % | 0.74 % |
|
Sakar Healthcare
|
Gufic Biosciences
|
Caplin Point Lab
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Wise Break-Up - API'S
|
Therapeutic Area Wise Break-Up - API'S
|
-
|
-
|